Categories: Wire Stories

Yiling Pharmaceutical, a Chinese Enterprise Going Global Under Intricate International Situations

SHIJIAZHUANG CITY, China–(BUSINESS WIRE)–In recent years, the advance of traditional Chinese medicine to the world has become a major trend. Acupuncture-moxibustion, massage and traditional Chinese herbal medicine have been recognized by more and more people from different countries and regions. As a pioneer of introducing traditional Chinese medicine to go global, Yiling Pharmaceutical has been committed to the causes of promoting the international exchange and cooperation of traditional Chinese medicine, promoting technologies, drugs and standard of traditional Chinese medicine to the world, and building an internationally famed brand of traditional Chinese medicine; meanwhile, Yiling has also tried to introduce excellent overseas technologies and products into China to give full play to its role as a bridge and link.

When the novel coronavirus pneumonia was seriously spreading in China, Yiling actively participated in the work of preventing and controlling the pandemic and its product Lianhua Qingwen Capsules was recommended for use by The Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia published by Chinese authorities. In addition, Yiling has also shouldered global responsibility as a Chinese enterprise by helping other countries fight against the pandemic. According to census, Yiling has donated through the Red Cross Society of China drugs and funds worth more than RMB 20 Million Yuan at home and abroad including 3.5 Million Yuan of Lianhua Qingwen Capsules to Italy, Thailand, Iraq and other countries, 3 Million Yuan of Lianhua Qingwen Capsules donated to Shanghai Cooperation Organization, 2 Million Yuan cash donated as international humanitarian assistance. Yiling is willing to share its experience of fighting the pandemic and experience of many years� medical research with the world.

Many of Yiling’s products have been well received in the international market. Lianhua Qingwen, its leading product, has recently obtained approval certificates from nearly 20 countries and regions, including the Philippines. According to reports, with the registration No. of THPR-50 in the Philippines, Lianhua Qingwen Capsules is categorized as a traditional plant medicine. At present, consumers in the Philippines can purchase Lianhua Qingwen at the South Star Drug, Watsons and Mercury Drug.

Contacts

First Name: Li

Last Name: Kristy

E-mail:kristyli@chuhaimedia.com.cn
Phone No.: +86 85962566

Alex

Recent Posts

Five Talent Shifts Redefining Hiring in Hong Kong: PERSOL Unveils 2025 Workforce Insights

PERSOL’s latest Industry Insight Report reveals how digitalisation, sustainability and shifting worker expectations are transforming…

1 hour ago

Chris Colahan to Join Chubb as Head of Commercial Property & Casualty, Asia Pacific

SINGAPORE - Media OutReach Newswire - 15 December 2025 - Chubb announced today the appointment…

3 hours ago

SEAX Global Acquires Major Stake in Interlink Telecom to Accelerate ASEAN Expansion

Acquisition creates a fully integrated regional connectivity platform, enabling seamless, low-latency connectivity that supports ASEAN’s…

2 days ago

M7 World Championship unveils first Opening Ceremony, tournament draw, and M7 Pass—elevates Indonesia on global stage

The Swiss Stage sets up early mouthwatering clashes between tournament favourites—Team Liquid face Aurora Gaming…

2 days ago

A First in the Asia-Pacific – Taiwan Leads the Launch of the Early Kidney Disease Annual Report, Opening a New Era in Advancing Kidney Care

TAIPEI, TAIWAN - Media OutReach Newswire - 11 December 2025 - Taiwan's chronic disease care…

2 days ago

The Government of Angola Launches an International Public Tender for the Management of the Namibe Corridor

LUANDA, ANGOLA - EQS Newswire - 12 December 2025 - The Ministry of Transport of…

2 days ago